For lipoprotein profiling the total and free cholesterol, and TG content in the different lipoprotein fractions corresponding to VLDL, LDL and HDL were determined after separation by size-exclusion chromatography 1 . Detailed analysis of lipoprotein subclasses as well as ApoA1 and ApoB were performed with Nuclear Magnetic Resonance spectroscopy (NMR) at Nightingale Health Ltd (formerly known as Brainshake) Laboratory, Vantaa, Finland 2 .
ApoCIII was analyzed using an enzyme-linked immunosorbent assay (Abcam, Cambridge, USA) following the manufacturer's instructions. Plasma and biliary lathosterol and campesterol were determined by isotope dilution-mass spectrometry after addition of deuterium labeled internal standards 3, 4 . The campesterol/cholesterol and the lathosterol/cholesterol ratios were calculated as biomarkers for intestinal cholesterol absorption and total body cholesterol synthesis, respectively [5] [6] [7] [8] . The intermediate in bile acid synthesis 7α-hydroxy-4-cholesten-3-one (C4) was analyzed in plasma samples by LC-MS/MS as described 9 .
Biliary lipids were extracted using the Bligh-Dyer method 10 . Cholesterol and phospholipid concentrations were determined by enzymatic methods with commercially available kits (Roche Diagnostics, Mannheim, Germany). Cholesterol saturation index (CSI) was calculated according to the critical tables described by Carey 11 . The individual bile acids were analyzed using GC-MS as previously described 12 . Briefly, bile was diluted with water, ethanol, KOH and hydrolyzed overnight after addition of deuterium labeled bile acids as internal standards.
After acidification with HCl to pH 1 the deconjugated bile acids were extracted with diethyl ether and trimethylsilylated prior injection into GC-MS (Agilent Technologies).
PG binding
In this study we used a solid phase binding procedure that has been found reproducible for evaluation of affinity of isolated, or in plasma, apoB-lipoproteins for human arterial proteoglycans or purified proteoglycans preparations 13, 14 . Human aortic PG were isolated from the intima-media of human aortas essentially by the method of Hurt-Camejo et al 15 16 .
Glycosaminoglycans were quantified by the method of Bartold and Page 17 , and the amounts of PG are expressed in terms of their glycosaminoglycan content. The wells of polystyrene 96-well plates (Thermo Fisher Scientific) were coated with 100 µL of the PGs (25 µg/mL in PBS) by incubation at 4°C overnight. Wells were blocked with 1% BSA in PBS for 1 h at 37°C. Wells without PG served as controls. One microliter of plasma was added to the wells in a buffer containing 140 mM NaCl, 2 mM MgCl2, 5 mM CaCl2 and 10 mM MES, pH 5.5
and incubated for 1 h at 37°C. The wells were washed with 10 mM MES-50 mM NaCl, pH 5.5, and the amount of bound cholesterol was determined using the Amplex Red cholesterol kit (Molecular Probes).
RNA extraction, cDNA synthesis and real-time RT-PCR
Total RNA was extracted and transcribed into cDNA using Omniscript (Qiagen, Sollentuna, Sweden). The mRNA expression levels were then quantified and using specific primers (Table 3) , arbitrary units were calculated by linearization of the CT values and normalized to glyceraldehyde-3-phosphate dehydrogenase (GAPDH).
Table S1. Lipid contribution in lipoprotein fractions used in Figure 2
Data show mean ± SEM. Plasma lipoproteins were subjected to analysis by nuclear magnetic resonance.
LDL: low density lipoprotein, HDL: high density lipoprotein, Remnant: non-HDL and non-LDL, P: placebo; S: simvastatin, E: ezetimibe, S+E: simvastatin plus ezetimibe.
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Pre- Data show mean ± SEM. Multi-Way ANOVA followed by LSD-test. NS: not significant.
